Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Dare Bioscience, Inc. |
| AGRANT◆ |
| 10,000 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 2,567 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 3,318 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 3,318 | — | — | +8.2% | Open the original filing on SEC.gov |
| May 5 | FATE | Fate Therapeutics INC | MEXER◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 5 | FATE | Fate Therapeutics INC | MEXER | 25,000 | $1.69 | $42.3K | +220.6% | Open the original filing on SEC.gov |